Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety Image Number 13 for United States Patent #8119616. The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.       Recently Added Patents Semiconductor fin device and method for forming the same using high tilt angle implant Receiving security risk feedback from linked contacts due to a user's system actions and behaviors Field-programmable analog array with memristors Cylindrical lithium secondary battery comprising a contoured center pin Transferring data by touch between touch-screen devices Information storage medium, reproducing method, and recording method Manufacturing aircraft parts   Randomly Featured Patents Process for the lost foam casting, under low pressure, of aluminium alloy articles Nephrolepis plant named `Sunjest` Enhanced products and processes for removing cavity tissue Process for forming a thin film of TiSiN, in particular for phase change memory devices MRI image enchancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands Sputtering using an unbalanced magnetron Kitchen faucet Method and apparatus for controlling air-fuel ratio in an internal combustion engine by corrective feedback control Carding flat structure Turfplaner with autograde and autodepth © 2006-2008 PatentGenius. All Rights Reserved.